Page last updated: 2024-10-24

1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine and Decerebrate Posturing

1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine has been researched along with Decerebrate Posturing in 1 studies

1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine: reported to have same biological activity as natural PAF-acether; RN given refers to parent cpd without isomeric designation

Research Excerpts

ExcerptRelevanceReference
" Since C18- AGPC suppressed not only the pressor response to noradrenaline but also to angiotensin II and vasopressin, and furthermore, did not disturb the dose-response curve of noradrenaline in the isolated aorta, the possibility of the agent being an alpha-adrenergic antagonist is ruled out."1.27Mechanism(s) of the hypotensive effect of synthetic 1-O-octadecyl-2-O-acetyl-glycero-3-phosphorylcholine. ( Kamitani, T; Katamoto, M; Katsuta, K; Kikuchi, H; Kumada, S; Ono, T; Tatsumi, M, 1984)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kamitani, T1
Katamoto, M1
Tatsumi, M1
Katsuta, K1
Ono, T1
Kikuchi, H1
Kumada, S1

Other Studies

1 other study available for 1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine and Decerebrate Posturing

ArticleYear
Mechanism(s) of the hypotensive effect of synthetic 1-O-octadecyl-2-O-acetyl-glycero-3-phosphorylcholine.
    European journal of pharmacology, 1984, Mar-02, Volume: 98, Issue:3-4

    Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Aorta, Thoracic; Atrial Function; Bl

1984